|
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002
|
SUZHOU, China, Sept. 27, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and m...
Full "IntellAsia: Resources" article
|
|